UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:ABCD3-AK5 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: ABCD3-AK5 | FusionPDB ID: 323 | FusionGDB2.0 ID: 323 | Hgene | Tgene | Gene symbol | ABCD3 | AK5 | Gene ID | 5825 | 26289 |
Gene name | ATP binding cassette subfamily D member 3 | adenylate kinase 5 | |
Synonyms | ABC43|CBAS5|PMP70|PXMP1|ZWS2 | AK6 | |
Cytomap | 1p21.3 | 1p31.1 | |
Type of gene | protein-coding | protein-coding | |
Description | ATP-binding cassette sub-family D member 370 kDa peroxisomal membrane proteinATP-binding cassette, sub-family D (ALD), member 3Peroxisomal membrane protein-1 (70kD)dJ824O18.1 (ATP-binding cassette, sub-family D (ALD), member 3 (PMP70, PXMP1))peroxiso | adenylate kinase isoenzyme 5AK 5ATP-AMP transphosphorylase 5adenylate kinase 6 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P28288 | Q9Y6K8 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000484213, ENST00000370214, ENST00000394233, ENST00000454898, ENST00000536817, ENST00000315713, | ENST00000344720, ENST00000354567, ENST00000317704, ENST00000478255, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 6 X 5 X 4=120 | 7 X 6 X 6=252 |
# samples | 6 | 7 | |
** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/252*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ABCD3 [Title/Abstract] AND AK5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ABCD3(94965170)-AK5(77876666), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ABCD3-AK5 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ABCD3-AK5 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ABCD3-AK5 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ABCD3-AK5 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ABCD3 | GO:0007031 | peroxisome organization | 9425230 |
Tgene | AK5 | GO:0006165 | nucleoside diphosphate phosphorylation | 23416111 |
Tgene | AK5 | GO:0009142 | nucleoside triphosphate biosynthetic process | 23416111 |
Fusion gene breakpoints across ABCD3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across AK5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-66-2756-01A | ABCD3 | chr1 | 94965170 | - | AK5 | chr1 | 77876666 | + |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000394233 | ABCD3 | chr1 | 94965170 | - | ENST00000354567 | AK5 | chr1 | 77876666 | + | 3606 | 1512 | 102 | 2309 | 735 |
ENST00000394233 | ABCD3 | chr1 | 94965170 | - | ENST00000344720 | AK5 | chr1 | 77876666 | + | 3602 | 1512 | 102 | 2309 | 735 |
ENST00000454898 | ABCD3 | chr1 | 94965170 | - | ENST00000354567 | AK5 | chr1 | 77876666 | + | 3972 | 1878 | 66 | 2675 | 869 |
ENST00000454898 | ABCD3 | chr1 | 94965170 | - | ENST00000344720 | AK5 | chr1 | 77876666 | + | 3968 | 1878 | 66 | 2675 | 869 |
ENST00000536817 | ABCD3 | chr1 | 94965170 | - | ENST00000354567 | AK5 | chr1 | 77876666 | + | 3861 | 1767 | 132 | 2564 | 810 |
ENST00000536817 | ABCD3 | chr1 | 94965170 | - | ENST00000344720 | AK5 | chr1 | 77876666 | + | 3857 | 1767 | 132 | 2564 | 810 |
ENST00000370214 | ABCD3 | chr1 | 94965170 | - | ENST00000354567 | AK5 | chr1 | 77876666 | + | 3858 | 1764 | 24 | 2561 | 845 |
ENST00000370214 | ABCD3 | chr1 | 94965170 | - | ENST00000344720 | AK5 | chr1 | 77876666 | + | 3854 | 1764 | 24 | 2561 | 845 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000394233 | ENST00000354567 | ABCD3 | chr1 | 94965170 | - | AK5 | chr1 | 77876666 | + | 0.000224371 | 0.9997756 |
ENST00000394233 | ENST00000344720 | ABCD3 | chr1 | 94965170 | - | AK5 | chr1 | 77876666 | + | 0.000224153 | 0.9997758 |
ENST00000454898 | ENST00000354567 | ABCD3 | chr1 | 94965170 | - | AK5 | chr1 | 77876666 | + | 0.000350045 | 0.99965 |
ENST00000454898 | ENST00000344720 | ABCD3 | chr1 | 94965170 | - | AK5 | chr1 | 77876666 | + | 0.000350577 | 0.9996494 |
ENST00000536817 | ENST00000354567 | ABCD3 | chr1 | 94965170 | - | AK5 | chr1 | 77876666 | + | 0.000369076 | 0.9996309 |
ENST00000536817 | ENST00000344720 | ABCD3 | chr1 | 94965170 | - | AK5 | chr1 | 77876666 | + | 0.000369022 | 0.9996309 |
ENST00000370214 | ENST00000354567 | ABCD3 | chr1 | 94965170 | - | AK5 | chr1 | 77876666 | + | 0.000139115 | 0.9998609 |
ENST00000370214 | ENST00000344720 | ABCD3 | chr1 | 94965170 | - | AK5 | chr1 | 77876666 | + | 0.000138865 | 0.9998611 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >323_323_1_ABCD3-AK5_ABCD3_chr1_94965170_ENST00000370214_AK5_chr1_77876666_ENST00000344720_length(amino acids)=845AA_BP=580 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNEKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIA VMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDN RIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNS RLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHNFILFRFSMGFIDSIIAKYLATVVGYLVVSRPFLDLSHPRHLKSTHSELLEDYYQS GRMLLRMSQALGRIVLAGREMTRLAGFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATP NGDVLIRDLNFEVRSGANVLICGPNGCGKSSLFRVLGELWPLFGGRLTKPERGKLFYVPQRPYMTLGTLRDQVIYPDGREDQKRKGISDL VLKEYLDNVQLGHILEREGGWDSVQDWMDVLSGGEKQRMAFDADRDEDEVFYDISMAVDNKLFPNKEAAAGSSDLDPSMILDTGEIIDTG SDYEDQGDDQLNVFGEDTMGGFMEDLRKCKIIFIIGGPGSGKGTQCEKLVEKYGFTHLSTGELLREELASESERSKLIRDIMERGDLVPS GIVLELLKEAMVASLGDTRGFLIDGYPREVKQGEEFGRRIGDPQLVICMDCSADTMTNRLLQRSRSSLPVDDTTKTIAKRLEAYYRASIP -------------------------------------------------------------- >323_323_2_ABCD3-AK5_ABCD3_chr1_94965170_ENST00000370214_AK5_chr1_77876666_ENST00000354567_length(amino acids)=845AA_BP=580 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNEKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIA VMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDN RIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNS RLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHNFILFRFSMGFIDSIIAKYLATVVGYLVVSRPFLDLSHPRHLKSTHSELLEDYYQS GRMLLRMSQALGRIVLAGREMTRLAGFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATP NGDVLIRDLNFEVRSGANVLICGPNGCGKSSLFRVLGELWPLFGGRLTKPERGKLFYVPQRPYMTLGTLRDQVIYPDGREDQKRKGISDL VLKEYLDNVQLGHILEREGGWDSVQDWMDVLSGGEKQRMAFDADRDEDEVFYDISMAVDNKLFPNKEAAAGSSDLDPSMILDTGEIIDTG SDYEDQGDDQLNVFGEDTMGGFMEDLRKCKIIFIIGGPGSGKGTQCEKLVEKYGFTHLSTGELLREELASESERSKLIRDIMERGDLVPS GIVLELLKEAMVASLGDTRGFLIDGYPREVKQGEEFGRRIGDPQLVICMDCSADTMTNRLLQRSRSSLPVDDTTKTIAKRLEAYYRASIP -------------------------------------------------------------- >323_323_3_ABCD3-AK5_ABCD3_chr1_94965170_ENST00000394233_AK5_chr1_77876666_ENST00000344720_length(amino acids)=735AA_BP=470 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNEKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIA VMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDN RIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNS RLITNSFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFEVRSGANVL ICGPNGCGKSSLFRVLGELWPLFGGRLTKPERGKLFYVPQRPYMTLGTLRDQVIYPDGREDQKRKGISDLVLKEYLDNVQLGHILEREGG WDSVQDWMDVLSGGEKQRMAFDADRDEDEVFYDISMAVDNKLFPNKEAAAGSSDLDPSMILDTGEIIDTGSDYEDQGDDQLNVFGEDTMG GFMEDLRKCKIIFIIGGPGSGKGTQCEKLVEKYGFTHLSTGELLREELASESERSKLIRDIMERGDLVPSGIVLELLKEAMVASLGDTRG FLIDGYPREVKQGEEFGRRIGDPQLVICMDCSADTMTNRLLQRSRSSLPVDDTTKTIAKRLEAYYRASIPVIAYYETKTQLHKINAEGTP -------------------------------------------------------------- >323_323_4_ABCD3-AK5_ABCD3_chr1_94965170_ENST00000394233_AK5_chr1_77876666_ENST00000354567_length(amino acids)=735AA_BP=470 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNEKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIA VMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDN RIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNS RLITNSFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFEVRSGANVL ICGPNGCGKSSLFRVLGELWPLFGGRLTKPERGKLFYVPQRPYMTLGTLRDQVIYPDGREDQKRKGISDLVLKEYLDNVQLGHILEREGG WDSVQDWMDVLSGGEKQRMAFDADRDEDEVFYDISMAVDNKLFPNKEAAAGSSDLDPSMILDTGEIIDTGSDYEDQGDDQLNVFGEDTMG GFMEDLRKCKIIFIIGGPGSGKGTQCEKLVEKYGFTHLSTGELLREELASESERSKLIRDIMERGDLVPSGIVLELLKEAMVASLGDTRG FLIDGYPREVKQGEEFGRRIGDPQLVICMDCSADTMTNRLLQRSRSSLPVDDTTKTIAKRLEAYYRASIPVIAYYETKTQLHKINAEGTP -------------------------------------------------------------- >323_323_5_ABCD3-AK5_ABCD3_chr1_94965170_ENST00000454898_AK5_chr1_77876666_ENST00000344720_length(amino acids)=869AA_BP=604 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGYFMETWREKSDEVMGELTDHVTHCKKSGKPPLQNNEKEGKKERAVVDKVFFSR LIQILKIMVPRTFCKETGYLVLIAVMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRV RLTKYLYEEYLQAFTYYKMGNLDNRIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTR LRRPIGKMTITEQKYEGEYRYVNSRLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHNFILFRFSMGFIDSIIAKYLATVVGYLVVSRP FLDLSHPRHLKSTHSELLEDYYQSGRMLLRMSQALGRIVLAGREMTRLAGFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPL IPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFEVRSGANVLICGPNGCGKSSLFRVLGELWPLFGGRLTKPERGKLFYVPQRPYMTL GTLRDQVIYPDGREDQKRKGISDLVLKEYLDNVQLGHILEREGGWDSVQDWMDVLSGGEKQRMAFDADRDEDEVFYDISMAVDNKLFPNK EAAAGSSDLDPSMILDTGEIIDTGSDYEDQGDDQLNVFGEDTMGGFMEDLRKCKIIFIIGGPGSGKGTQCEKLVEKYGFTHLSTGELLRE ELASESERSKLIRDIMERGDLVPSGIVLELLKEAMVASLGDTRGFLIDGYPREVKQGEEFGRRIGDPQLVICMDCSADTMTNRLLQRSRS -------------------------------------------------------------- >323_323_6_ABCD3-AK5_ABCD3_chr1_94965170_ENST00000454898_AK5_chr1_77876666_ENST00000354567_length(amino acids)=869AA_BP=604 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGYFMETWREKSDEVMGELTDHVTHCKKSGKPPLQNNEKEGKKERAVVDKVFFSR LIQILKIMVPRTFCKETGYLVLIAVMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRV RLTKYLYEEYLQAFTYYKMGNLDNRIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTR LRRPIGKMTITEQKYEGEYRYVNSRLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHNFILFRFSMGFIDSIIAKYLATVVGYLVVSRP FLDLSHPRHLKSTHSELLEDYYQSGRMLLRMSQALGRIVLAGREMTRLAGFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPL IPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFEVRSGANVLICGPNGCGKSSLFRVLGELWPLFGGRLTKPERGKLFYVPQRPYMTL GTLRDQVIYPDGREDQKRKGISDLVLKEYLDNVQLGHILEREGGWDSVQDWMDVLSGGEKQRMAFDADRDEDEVFYDISMAVDNKLFPNK EAAAGSSDLDPSMILDTGEIIDTGSDYEDQGDDQLNVFGEDTMGGFMEDLRKCKIIFIIGGPGSGKGTQCEKLVEKYGFTHLSTGELLRE ELASESERSKLIRDIMERGDLVPSGIVLELLKEAMVASLGDTRGFLIDGYPREVKQGEEFGRRIGDPQLVICMDCSADTMTNRLLQRSRS -------------------------------------------------------------- >323_323_7_ABCD3-AK5_ABCD3_chr1_94965170_ENST00000536817_AK5_chr1_77876666_ENST00000344720_length(amino acids)=810AA_BP=545 MPAPQAAPRPRPARKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIAVMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRY LLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDNRIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIV LYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNSRLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHN FILFRFSMGFIDSIIAKYLATVVGYLVVSRPFLDLSHPRHLKSTHSELLEDYYQSGRMLLRMSQALGRIVLAGREMTRLAGFTARITELM QVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFEVRSGANVLICGPNGCGKSSLFRV LGELWPLFGGRLTKPERGKLFYVPQRPYMTLGTLRDQVIYPDGREDQKRKGISDLVLKEYLDNVQLGHILEREGGWDSVQDWMDVLSGGE KQRMAFDADRDEDEVFYDISMAVDNKLFPNKEAAAGSSDLDPSMILDTGEIIDTGSDYEDQGDDQLNVFGEDTMGGFMEDLRKCKIIFII GGPGSGKGTQCEKLVEKYGFTHLSTGELLREELASESERSKLIRDIMERGDLVPSGIVLELLKEAMVASLGDTRGFLIDGYPREVKQGEE FGRRIGDPQLVICMDCSADTMTNRLLQRSRSSLPVDDTTKTIAKRLEAYYRASIPVIAYYETKTQLHKINAEGTPEDVFLQLCTAIDSIF -------------------------------------------------------------- >323_323_8_ABCD3-AK5_ABCD3_chr1_94965170_ENST00000536817_AK5_chr1_77876666_ENST00000354567_length(amino acids)=810AA_BP=545 MPAPQAAPRPRPARKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIAVMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRY LLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDNRIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIV LYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNSRLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHN FILFRFSMGFIDSIIAKYLATVVGYLVVSRPFLDLSHPRHLKSTHSELLEDYYQSGRMLLRMSQALGRIVLAGREMTRLAGFTARITELM QVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFEVRSGANVLICGPNGCGKSSLFRV LGELWPLFGGRLTKPERGKLFYVPQRPYMTLGTLRDQVIYPDGREDQKRKGISDLVLKEYLDNVQLGHILEREGGWDSVQDWMDVLSGGE KQRMAFDADRDEDEVFYDISMAVDNKLFPNKEAAAGSSDLDPSMILDTGEIIDTGSDYEDQGDDQLNVFGEDTMGGFMEDLRKCKIIFII GGPGSGKGTQCEKLVEKYGFTHLSTGELLREELASESERSKLIRDIMERGDLVPSGIVLELLKEAMVASLGDTRGFLIDGYPREVKQGEE FGRRIGDPQLVICMDCSADTMTNRLLQRSRSSLPVDDTTKTIAKRLEAYYRASIPVIAYYETKTQLHKINAEGTPEDVFLQLCTAIDSIF -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:94965170/chr1:77876666) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ABCD3 | AK5 |
FUNCTION: Probable transporter involved in the transport of branched-chain fatty acids and C27 bile acids into the peroxisome; the latter function is a crucial step in bile acid biosynthesis (PubMed:25168382). The nucleotide-binding fold acts as an ATP-binding subunit with ATPase activity (PubMed:11248239). {ECO:0000269|PubMed:11248239, ECO:0000269|PubMed:25168382}. | FUNCTION: Nucleoside monophosphate (NMP) kinase that catalyzes the reversible transfer of the terminal phosphate group between nucleoside triphosphates and monophosphates. Active on AMP and dAMP with ATP as a donor. When GTP is used as phosphate donor, the enzyme phosphorylates AMP, CMP, and to a small extent dCMP. Also displays broad nucleoside diphosphate kinase activity. {ECO:0000269|PubMed:19647735, ECO:0000269|PubMed:23416111}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000370214 | - | 20 | 23 | 85_372 | 580.0 | 660.0 | Domain | ABC transmembrane type-1 |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000394233 | - | 16 | 19 | 85_372 | 470.0 | 550.0 | Domain | ABC transmembrane type-1 |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000370214 | - | 20 | 23 | 473_480 | 580.0 | 660.0 | Nucleotide binding | ATP |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000370214 | - | 20 | 23 | 1_124 | 580.0 | 660.0 | Region | Note=Targeting to peroxisomes |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000394233 | - | 16 | 19 | 1_124 | 470.0 | 550.0 | Region | Note=Targeting to peroxisomes |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000370214 | - | 20 | 23 | 126_146 | 580.0 | 660.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000370214 | - | 20 | 23 | 224_244 | 580.0 | 660.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000370214 | - | 20 | 23 | 313_333 | 580.0 | 660.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000370214 | - | 20 | 23 | 84_104 | 580.0 | 660.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000394233 | - | 16 | 19 | 126_146 | 470.0 | 550.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000394233 | - | 16 | 19 | 224_244 | 470.0 | 550.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000394233 | - | 16 | 19 | 313_333 | 470.0 | 550.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000394233 | - | 16 | 19 | 84_104 | 470.0 | 550.0 | Transmembrane | Helical |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 386_391 | 271.0 | 537.0 | Nucleotide binding | ATP 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 433_435 | 271.0 | 537.0 | Nucleotide binding | AMP 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 462_465 | 271.0 | 537.0 | Nucleotide binding | AMP 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 386_391 | 297.0 | 563.0 | Nucleotide binding | ATP 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 433_435 | 297.0 | 563.0 | Nucleotide binding | AMP 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 462_465 | 297.0 | 563.0 | Nucleotide binding | AMP 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 377_559 | 271.0 | 537.0 | Region | Adenylate kinase 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 406_435 | 271.0 | 537.0 | Region | NMP 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 499_509 | 271.0 | 537.0 | Region | LID 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 377_559 | 297.0 | 563.0 | Region | Adenylate kinase 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 406_435 | 297.0 | 563.0 | Region | NMP 2 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 499_509 | 297.0 | 563.0 | Region | LID 2 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000315713 | - | 1 | 9 | 440_659 | 0.0 | 237.0 | Domain | ABC transporter |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000315713 | - | 1 | 9 | 85_372 | 0.0 | 237.0 | Domain | ABC transmembrane type-1 |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000370214 | - | 20 | 23 | 440_659 | 580.0 | 660.0 | Domain | ABC transporter |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000394233 | - | 16 | 19 | 440_659 | 470.0 | 550.0 | Domain | ABC transporter |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000315713 | - | 1 | 9 | 473_480 | 0.0 | 237.0 | Nucleotide binding | ATP |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000394233 | - | 16 | 19 | 473_480 | 470.0 | 550.0 | Nucleotide binding | ATP |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000315713 | - | 1 | 9 | 1_124 | 0.0 | 237.0 | Region | Note=Targeting to peroxisomes |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000315713 | - | 1 | 9 | 126_146 | 0.0 | 237.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000315713 | - | 1 | 9 | 224_244 | 0.0 | 237.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000315713 | - | 1 | 9 | 313_333 | 0.0 | 237.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000315713 | - | 1 | 9 | 84_104 | 0.0 | 237.0 | Transmembrane | Helical |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 142_147 | 271.0 | 537.0 | Nucleotide binding | ATP 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 191_193 | 271.0 | 537.0 | Nucleotide binding | AMP 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 219_222 | 271.0 | 537.0 | Nucleotide binding | AMP 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 142_147 | 297.0 | 563.0 | Nucleotide binding | ATP 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 191_193 | 297.0 | 563.0 | Nucleotide binding | AMP 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 219_222 | 297.0 | 563.0 | Nucleotide binding | AMP 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 133_316 | 271.0 | 537.0 | Region | Adenylate kinase 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 162_193 | 271.0 | 537.0 | Region | NMP 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000344720 | 5 | 14 | 256_266 | 271.0 | 537.0 | Region | LID 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 133_316 | 297.0 | 563.0 | Region | Adenylate kinase 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 162_193 | 297.0 | 563.0 | Region | NMP 1 | |
Tgene | AK5 | chr1:94965170 | chr1:77876666 | ENST00000354567 | 5 | 14 | 256_266 | 297.0 | 563.0 | Region | LID 1 |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
ABCD3 | |
AK5 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | ABCD3 | chr1:94965170 | chr1:77876666 | ENST00000315713 | - | 1 | 9 | 1_199 | 0.0 | 237.0 | PEX19 |
Top |
Related Drugs to ABCD3-AK5 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ABCD3-AK5 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |